JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -85.7% | 355 | -83.8% | 0.00% | – |
| Q2 2022 | $7,000 | -77.4% | 2,190 | -52.5% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | +47.6% | 4,606 | +129.3% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +61.5% | 2,009 | +22.4% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | +62.5% | 1,642 | +89.0% | 0.00% | -50.0% |
| Q4 2019 | $8,000 | +700.0% | 869 | +2533.3% | 0.00% | +100.0% |
| Q1 2018 | $1,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |